These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34301651)

  • 21. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study.
    Zhang AZ; Enns EA
    BMC Public Health; 2022 Apr; 22(1):679. PubMed ID: 35392861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US.
    Flaxman AD; Issema R; Barnabas RV; Ross JM
    JAMA Netw Open; 2022 Apr; 5(4):e228632. PubMed ID: 35452104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 among people experiencing homelessness in England: a modelling study.
    Lewer D; Braithwaite I; Bullock M; Eyre MT; White PJ; Aldridge RW; Story A; Hayward AC
    Lancet Respir Med; 2020 Dec; 8(12):1181-1191. PubMed ID: 32979308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 pandemic in Malawi: Did public sociopolitical events gatherings contribute to its first-wave local transmission?
    Nyasulu JCY; Munthali RJ; Nyondo-Mipando AL; Pandya H; Nyirenda L; Nyasulu PS; Manda S
    Int J Infect Dis; 2021 May; 106():269-275. PubMed ID: 33771674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa.
    Mabuka T; Ncube N; Ross M; Silaji A; Macharia W; Ndemera T; Lemeke T
    BMC Public Health; 2023 Aug; 23(1):1492. PubMed ID: 37542267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Infection fatality rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].
    Zejda JE; Kowalska M; Brożek GM; Barański K; Kaleta-Pilarska A
    Med Pr; 2021 Dec; 72(6):671-676. PubMed ID: 34751682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies.
    Keeling MJ; Hill EM; Gorsich EE; Penman B; Guyver-Fletcher G; Holmes A; Leng T; McKimm H; Tamborrino M; Dyson L; Tildesley MJ
    PLoS Comput Biol; 2021 Jan; 17(1):e1008619. PubMed ID: 33481773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mathematical-adapted model to analyze the characteristics for the mortality of COVID-19.
    Hao B; Liu C; Wang Y; Zhu N; Ding Y; Wu J; Wang Y; Sun F; Chen L
    Sci Rep; 2022 Mar; 12(1):5493. PubMed ID: 35361868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated Demand for US Hospital Inpatient and Intensive Care Unit Beds for Patients With COVID-19 Based on Comparisons With Wuhan and Guangzhou, China.
    Li R; Rivers C; Tan Q; Murray MB; Toner E; Lipsitch M
    JAMA Netw Open; 2020 May; 3(5):e208297. PubMed ID: 32374400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada.
    Tuite AR; Fisman DN; Greer AL
    CMAJ; 2020 May; 192(19):E497-E505. PubMed ID: 32269018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study.
    Zu J; Li ML; Li ZF; Shen MW; Xiao YN; Ji FP
    Infect Dis Poverty; 2020 Jul; 9(1):83. PubMed ID: 32631426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.